Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Published Online: 2020-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alexander Drilon•Alice T Shaw•Ann Johnson•Brian Simmons•Byoung Chul Cho•Chao-Hua Chiu•Chia-Chi Lin•Christian Rolfo•Christine H Chung•Christos S Karapetis•Daniel S W Tan•Edna Chow-Maneval•Fabrice Barlesi•Filippo de Braud•Gregory A Otterson•Hans Prenen•Haruyasu Murakami•Hendrick-Tobias Arkenau•Jürgen Wolf•Koichi Goto•Manish R Patel•Matthew G Krebs•Myung-Ju Ahn•Na Cui•Rafal Dziadziuszko•Robert C Doebele•Salvatore Siena•Sang-We Kim•Susan Eng•Takashi Seto•Thomas John•Timothy R Wilson•Todd Riehl•Young K Chae•Yu-Chung Li•Yuichiro Ohe
